Company intelligence / Profile preview
Carisma Therapeutics
Philadelphia, Pennsylvania, United States
- Ownership
- Public · CARM
- Employees
- ~40
- Development stage
- Other
01
Overview
Carisma's liver fibrosis program (CT-2401) has achieved preclinical proof of concept, showing anti-fibrotic activity in mouse models[1]. Its oncology program (CT-1119) reached IND-enabling/preclinical stage, planning a Phase 1 trial in China before operations were paused[1]. The Moderna collaboration yielded robust preclinical anti-tumor activity for CAR-M therapies targeting glypican-3, with 12 targets nominated, but Carisma will no longer conduct further R&D on this partnership[1].
- Therapeutic areas
- OncologyGastroenterology
- Modalities
- Cell therapyCAR-macrophage therapyCAR-monocyte therapymRNA-based drugsLipid nanoparticle delivery therapy
- Industry
- Biotech
02
Drug pipeline
21 assets20 more assets in the full pipeline.
Request access →03
Partnerships
Moderna (CAR-M collaboration for oncology, now terminated for funding but milestone/royalty rights remain)[1]
Beyond the preview
Go deeper on Carisma Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Carisma Therapeutics.